Efeitos dos Fitoestrogênios sobre Alguns Parâmetros Clínicos e Laboratoriais no Climatério

• Autor(a) principal: Han, Kyung Koo [UNIFESP]
• Data de Publicação: 2002
• Outros Autores: Soares Júnior, José Maria [UNIFESP], Haidar, Mauro Abi [UNIFESP], Girão, Manoel João Batista Castello [UNIFESP], Nunes, Marcia Gaspar [UNIFESP], Lima, Geraldo Rodrigues de [UNIFESP], Baracat, Edmund Chada [UNIFESP]
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UNIFESP
• Texto Completo: http://dx.doi.org/10.1590/S0100-72032002000800008; http://repositorio.unifesp.br/handle/11600/1517
• topic: Phytoestrogen; Menopause; Climacterium; Kupperman index; Fitoestrogênio; Climatério; Menopausa; Índice de Kupperman

Purpose: to evaluate the estrogenic effects of soy phytoestrogens in postmenopausal patients. Method: we selected postmenopausal patients from the Climacteric Service of the Gynecology Department of the Federal University of São Paulo - Escola Paulista de Medicina. The patients were divided into two groups: GI (n=40) received daily 100 mg isoflavone (3 x 33.3 mg/day); and GCtr (n=40) received daily placebo. We included in this study the Kuppermann menopausal index, physical examination and the biochemical determination of total and fractions of cholesterol, triglycerides, estradiol, FSH e LH. We also performed sonographic examination to measure endometrial thickness. To compare baseline and after treatment values of both groups, the nonparametric Kruskal-Wallis test was used for the Kuppermann index, while the t test was performed for other data. Results: evaluation of the Kupperman Menopausal Index, 80% patients of GI showed a decrease in the total score, while the improvement of symptoms in GCtr was 12,5%. The analysis of total cholesterol levels showed that 35 patients of GI had levels above 200 mg/dL, and only 13 of GCtr presented similar levels. The body mass index reduction occurred in GI and the control group showed no changes. We also verified that echo endometrial thickness and FSH levels were similar to baseline values. However the values of estrogen increased after isoflavone treatment. Conclusion: we concluded that 100 mg/day isoflavone may be an alternative treatment for attenuating the climacteric symptoms in 80% of isoflavone users and that it reduced total cholesterol.